Anlotinib in Metastatic HER2 Negative Breast Cancer
Clinical trial NCT04002284 · COMPLETED
Trial details
- NCT number
- NCT04002284
- Sponsor
- Peng Yuan
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-07-12
- Primary completion
- 2020-01-10
- Enrollment
- 26
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.